← Evidence map

ArticleVacunas2023

Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece.

Petros Galanis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37362837